(-)-Cevimeline hydrochloride risodium salt Co-incubation of pulmonary arterial smooth
Pay in 4 interest-free payments of $30.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Live Spec
(-)-Cevimeline hydrochloride risodium salt Co-incubation of pulmonary arterial smooth( ) Cevimeline hydrochloride hemihydrate (( ) SNI 2011), a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI 2011 was also evaluated with rat and dog liver
Store: clickpoint.com.au · Domain: clickpoint.com.au

























